Skip to content

Clinical trials

Gastrointestinal Stromal Tumors trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Gastrointestinal Stromal Tumors Country / region: Canada Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20052
20072
20081
20092
20112
20131
20142
20151
20162
20172
20182
20191
20221
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting5
Terminated4
Active, not recruiting2
Unknown status2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Deciphera Pharmaceuticals, LLC4
Bayer2
GlaxoSmithKline2
National Cancer Institute (NCI)2
Pfizer2
Blueprint Medicines Corporation1
British Columbia Cancer Agency1
Cogent Biosciences, Inc.1
Esperas Pharma Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Gastrointestinal Stromal Tumors28
Breast Neoplasms5
Sarcoma5
Neoplasm Metastasis4
Ovarian Neoplasms4
Biliary Tract Neoplasms3
Colorectal Neoplasms3
Endometrial Neoplasms3
Gastrointestinal Neoplasms3
Glioma3

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.